Denosumab: A New Treatment for Osteoporosis

    loading  Checking for direct PDF access through Ovid

Abstract

Synopsis:

Denosumab, a human antibody, effectively increases bone mineral density in postmenopausal women.

Source:

Miller PD, et al. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial. Bone 2008;43:222-229.

Related Topics

    loading  Loading Related Articles